Weight Loss-Independent Changes in Human Growth Hormone During Water-Only Fasting: A Secondary Evaluation of a Randomized Controlled Trial - Horne, Benjamin D.; Anderson, Jeffrey L.; May, Heidi T.; Bair, Tami L.; Le, Viet T.; Iverson, Leslie; Knowlton, Kirk U.; Muhlestein, Joseph B. (medRxiv, 2024)
Introduction Water-only fasting for one day or more may provide health benefits independent of weight loss. Human growth hormone (HGH) may play a key role in multiple fasting-triggered mechanisms. Whether HGH changes during fasting are independent of weight loss and how basal HGH and HGH change relate to other fasting-induced changes are unknown.Methods Apparently healthy individuals (N=30) were randomized by Latin square to begin two days with either 24-hour water-only fasting or a control of 24-hour ad libitum eating. On day 2, subjects were crossed over to control (if day 1 was fasting) or fasting (if they ate on day 1). HGH, weight, and other parameters were measured at baseline and at the end of the first and second days.Results Baseline HGH had median 0.50 ng/mL for females (n=20) and 0.04 ng/mL for males (n=10), and correlated inversely with weight, glucose, insulin, and triglycerides and positively with changes in insulin and HOMA-IR. The 24-hour fasting-induced HGH change was uncorrelated with weight loss (r= 0.01, p=0.98), but correlated with changes in glucose, HGB, and IGF-1. The percent increase in HGH was greater (p<0.001) for lower (females <=0.15 ng/mL, males <=0.05 ng/mL) vs. higher baseline HGH (median: 1,225% vs. 50.3%, respectively). Subjects with lower baseline HGH had a trend to greater reduction of HOMA-IR (median: -6.15 vs. -1.35 for lower vs. higher HGH, respectively, p=0.08).Conclusions Fasting increased HGH and the HGH changes were independent of weight loss. Basal HGH and fasting-induced HGH changes correlated inversely with cardiometabolic risk factors.Competing Interest StatementThe authors have no conflicts of interest related to this study. Outside this work, BDH is a member of the advisory board of Unleash Health and previously consulted for Pfizer regarding risk scores (funds paid to Intermountain). KUK and BDH are site PIs of grants from the Patient-Centered Outcomes Research Institute and the NIH RECOVER initiative, and BDH is site PI of a grant from the Task Force for Global Health. The authors declare no other potential conflicts of interest.Clinical TrialNCT010159760Funding StatementThis research was funded by a grant from the Intermountain Research and Medical Foundation that was provided through the philanthropy of the Dell Loy Hansen Heart Foundation. The funding sources had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Intermountain Health Institutional Review Board approved the trial and it was registered at ClinicalTrials.gov (NCT010159760) before any subjects were enrolled (January 28, 2010).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data underlying this article cannot be shared publicly due to United States privacy laws. The data will be shared on reasonable request to the corresponding author.